TY - BOOK ID - 134320823 TI - The Immunology and Biology of Brain Tumors PY - 2021 PB - Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute DB - UniCat KW - Medicine KW - vaccine therapy KW - oncoantigen KW - tumor associate antigen KW - tumor angiogenesis KW - high-grade glioma KW - pituitary neuroendocrine tumors KW - VEGF KW - Treg KW - TAM KW - PD-1 KW - PD-L1 KW - tumor microenvironment (TME) KW - glioblastoma multiforme (GBM) KW - GBM-associated macrophages (GAMs) KW - exosomes KW - oncomiR-21 KW - STAT3 inhibitor KW - glioma KW - diffusion tensor imaging KW - generalized q-ball imaging KW - treatment-related effects KW - multiple resections KW - adrenal insufficiency KW - Addison’s disease KW - bevacizumab KW - cerebral radiation necrosis KW - craniopharyngioma KW - inflammation KW - checkpoint inhibitors KW - Interleukin-6 UR - https://www.unicat.be/uniCat?func=search&query=sysid:134320823 AB - Immunotherapy has become a viable treatment modality for a variety of cancers (and referred to as Science Magazine’s “Breakthrough of the Year” in 2013, as well as ASCO’s “Advance of the Year” in both 2016 and 2017). This Special Issue is focused on the relevance of immunobiology in brain tumors, touching on elements of immune suppression, immune stimulation, and the immune microenvironment, with culminations in translational immunotherapy. ER -